2-[2,5-bis[5-(3-bicyclo[4.2.0]octa-1(6),2,4-trienyl)pentyl]-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl]-4,4,5,5-tetramethyl-1,3,2-dioxaborolane;2-N,7-N-bis(4-bromophenyl)-9-(3,5-dihexylphenyl)-9-octyl-2-N,7-N-bis(2,4,6-trimethylphenyl)fluorene-2,7-diamine;2,4-bis(4-tert-butylphenyl)-6-(6-phenyl-3-pyridinyl)-1,3,5-triazine;2-[2,5-bis(hex-5-enyl)-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl]-4,4,5,5-tetramethyl-1,3,2-dioxaborolane;2-[6-(3-bromobenzene-6-id-1-yl)-3-pyridinyl]-4,6-bis(4-tert-butylphenyl)-1,3,5-triazine;iridium

C211H255B4Br3IrN10O8-2 — CID 159314253

IUPAC2-[2,5-bis[5-(3-bicyclo[4.2.0]octa-1(6),2,4-trienyl)pentyl]-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl]-4,4,5,5-tetramethyl-1,3,2-dioxaborolane;2-N,7-N-bis(4-bromophenyl)-9-(3,5-dihexylphenyl)-9-octyl-2-N,7-N-bis(2,4,6-trimethylphenyl)fluorene-2,7-diamine;2,4-bis(4-tert-butylphenyl)-6-(6-phenyl-3-pyridinyl)-1,3,5-triazine;2-[2,5-bis(hex-5-enyl)-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl]-4,4,5,5-tetramethyl-1,3,2-dioxaborolane;2-[6-(3-bromobenzene-6-id-1-yl)-3-pyridinyl]-4,6-bis(4-tert-butylphenyl)-1,3,5-triazine;iridium
SMILESC=CCCCCc1cc(B2OC(C)(C)C(C)(C)O2)c(CCCCC=C)cc1B1OC(C)(C)C(C)(C)O1.CC(C)(C)c1ccc(-c2nc(-c3ccc(C(C)(C)C)cc3)nc(-c3ccc(-c4[c-]ccc(Br)c4)nc3)n2)cc1.CC(C)(C)c1ccc(-c2nc(-c3ccc(C(C)(C)C)cc3)nc(-c3ccc(-c4[c-]cccc4)nc3)n2)cc1.CC1(C)OB(c2cc(CCCCCc3ccc4c(c3)CC4)c(B3OC(C)(C)C(C)(C)O3)cc2CCCCCc2ccc3c(c2)CC3)OC1(C)C.CCCCCCCCC1(c2cc(CCCCCC)cc(CCCCCC)c2)c2cc(N(c3ccc(Br)cc3)c3c(C)cc(C)cc3C)ccc2-c2ccc(N(c3ccc(Br)cc3)c3c(C)cc(C)cc3C)cc21.[Ir]
InChIInChI=1S/C69H82Br2N2.C44H60B2O4.C34H32BrN4.C34H33N4.C30H48B2O4.Ir/c1-10-13-16-19-20-23-38-69(56-44-54(24-21-17-14-11-2)43-55(45-56)25-22-18-15-12-3)65-46-61(72(59-30-26-57(70)27-31-59)67-50(6)39-48(4)40-51(67)7)34-36-63(65)64-37-35-62(47-66(64)69)73(60-32-28-58(71)29-33-60)68-52(8)41-49(5)42-53(68)9;1-41(2)42(3,4)48-45(47-41)39-29-38(18-14-10-12-16-32-20-22-34-24-26-36(34)28-32)40(46-49-43(5,6)44(7,8)50-46)30-37(39)17-13-9-11-15-31-19-21-33-23-25-35(33)27-31;1-33(2,3)26-15-10-22(11-16-26)30-37-31(23-12-17-27(18-13-23)34(4,5)6)39-32(38-30)25-14-19-29(36-21-25)24-8-7-9-28(35)20-24;1-33(2,3)27-17-12-24(13-18-27)30-36-31(25-14-19-28(20-15-25)34(4,5)6)38-32(37-30)26-16-21-29(35-22-26)23-10-8-7-9-11-23;1-11-13-15-17-19-23-21-26(32-35-29(7,8)30(9,10)36-32)24(20-18-16-14-12-2)22-25(23)31-33-27(3,4)28(5,6)34-31;/h26-37,39-47H,10-25,38H2,1-9H3;19-22,27-30H,9-18,23-26H2,1-8H3;7,9-21H,1-6H3;7-10,12-22H,1-6H3;11-12,21-22H,1-2,13-20H2,3-10H3;/q;;2*-1;;
InChIKeyOBTOXSXPJJEEFI-UHFFFAOYSA-N
MW3534.60 g/mol
LogP54.21
Rot. Bonds58

About 2-[2,5-bis[5-(3-bicyclo[4.2.0]octa-1(6),2,4-trienyl)pentyl]-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl]-4,4,5,5-tetramethyl-1,3,2-dioxaborolane;2-N,7-N-bis(4-bromophenyl)-9-(3,5-dihexylphenyl)-9-octyl-2-N,7-N-bis(2,4,6-trimethylphenyl)fluorene-2,7-diamine;2,4-bis(4-tert-butylphenyl)-6-(6-phenyl-3-pyridinyl)-1,3,5-triazine;2-[2,5-bis(hex-5-enyl)-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl]-4,4,5,5-tetramethyl-1,3,2-dioxaborolane;2-[6-(3-bromobenzene-6-id-1-yl)-3-pyridinyl]-4,6-bis(4-tert-butylphenyl)-1,3,5-triazine;iridium

2-[2,5-bis[5-(3-bicyclo[4.2.0]octa-1(6),2,4-trienyl)pentyl]-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl]-4,4,5,5-tetramethyl-1,3,2-dioxaborolane;2-N,7-N-bis(4-bromophenyl)-9-(3,5-dihexylphenyl)-9-octyl-2-N,7-N-bis(2,4,6-trimethylphenyl)fluorene-2,7-diamine;2,4-bis(4-tert-butylphenyl)-6-(6-phenyl-3-pyridinyl)-1,3,5-triazine;2-[2,5-bis(hex-5-enyl)-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl]-4,4,5,5-tetramethyl-1,3,2-dioxaborolane;2-[6-(3-bromobenzene-6-id-1-yl)-3-pyridinyl]-4,6-bis(4-tert-butylphenyl)-1,3,5-triazine;iridium (PubChem CID 159314253) has the molecular formula C211H255B4Br3IrN10O8-2 and a molecular weight of 3534.60 g/mol. Its IUPAC name is 2-[2,5-bis[5-(3-bicyclo[4.2.0]octa-1(6),2,4-trienyl)pentyl]-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl]-4,4,5,5-tetramethyl-1,3,2-dioxaborolane;2-N,7-N-bis(4-bromophenyl)-9-(3,5-dihexylphenyl)-9-octyl-2-N,7-N-bis(2,4,6-trimethylphenyl)fluorene-2,7-diamine;2,4-bis(4-tert-butylphenyl)-6-(6-phenyl-3-pyridinyl)-1,3,5-triazine;2-[2,5-bis(hex-5-enyl)-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl]-4,4,5,5-tetramethyl-1,3,2-dioxaborolane;2-[6-(3-bromobenzene-6-id-1-yl)-3-pyridinyl]-4,6-bis(4-tert-butylphenyl)-1,3,5-triazine;iridium.

Molecular Properties

Compound Name2-[2,5-bis[5-(3-bicyclo[4.2.0]octa-1(6),2,4-trienyl)pentyl]-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl]-4,4,5,5-tetramethyl-1,3,2-dioxaborolane;2-N,7-N-bis(4-bromophenyl)-9-(3,5-dihexylphenyl)-9-octyl-2-N,7-N-bis(2,4,6-trimethylphenyl)fluorene-2,7-diamine;2,4-bis(4-tert-butylphenyl)-6-(6-phenyl-3-pyridinyl)-1,3,5-triazine;2-[2,5-bis(hex-5-enyl)-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl]-4,4,5,5-tetramethyl-1,3,2-dioxaborolane;2-[6-(3-bromobenzene-6-id-1-yl)-3-pyridinyl]-4,6-bis(4-tert-butylphenyl)-1,3,5-triazine;iridium
PubChem CID159314253
Molecular FormulaC211H255B4Br3IrN10O8-2
Molecular Weight3534.60 g/mol
Exact Mass3530.74
IUPAC Name2-[2,5-bis[5-(3-bicyclo[4.2.0]octa-1(6),2,4-trienyl)pentyl]-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl]-4,4,5,5-tetramethyl-1,3,2-dioxaborolane;2-N,7-N-bis(4-bromophenyl)-9-(3,5-dihexylphenyl)-9-octyl-2-N,7-N-bis(2,4,6-trimethylphenyl)fluorene-2,7-diamine;2,4-bis(4-tert-butylphenyl)-6-(6-phenyl-3-pyridinyl)-1,3,5-triazine;2-[2,5-bis(hex-5-enyl)-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl]-4,4,5,5-tetramethyl-1,3,2-dioxaborolane;2-[6-(3-bromobenzene-6-id-1-yl)-3-pyridinyl]-4,6-bis(4-tert-butylphenyl)-1,3,5-triazine;iridium
SMILESC=CCCCCc1cc(B2OC(C)(C)C(C)(C)O2)c(CCCCC=C)cc1B1OC(C)(C)C(C)(C)O1.CC(C)(C)c1ccc(-c2nc(-c3ccc(C(C)(C)C)cc3)nc(-c3ccc(-c4[c-]ccc(Br)c4)nc3)n2)cc1.CC(C)(C)c1ccc(-c2nc(-c3ccc(C(C)(C)C)cc3)nc(-c3ccc(-c4[c-]cccc4)nc3)n2)cc1.CC1(C)OB(c2cc(CCCCCc3ccc4c(c3)CC4)c(B3OC(C)(C)C(C)(C)O3)cc2CCCCCc2ccc3c(c2)CC3)OC1(C)C.CCCCCCCCC1(c2cc(CCCCCC)cc(CCCCCC)c2)c2cc(N(c3ccc(Br)cc3)c3c(C)cc(C)cc3C)ccc2-c2ccc(N(c3ccc(Br)cc3)c3c(C)cc(C)cc3C)cc21.[Ir]
InChIInChI=1S/C69H82Br2N2.C44H60B2O4.C34H32BrN4.C34H33N4.C30H48B2O4.Ir/c1-10-13-16-19-20-23-38-69(56-44-54(24-21-17-14-11-2)43-55(45-56)25-22-18-15-12-3)65-46-61(72(59-30-26-57(70)27-31-59)67-50(6)39-48(4)40-51(67)7)34-36-63(65)64-37-35-62(47-66(64)69)73(60-32-28-58(71)29-33-60)68-52(8)41-49(5)42-53(68)9;1-41(2)42(3,4)48-45(47-41)39-29-38(18-14-10-12-16-32-20-22-34-24-26-36(34)28-32)40(46-49-43(5,6)44(7,8)50-46)30-37(39)17-13-9-11-15-31-19-21-33-23-25-35(33)27-31;1-33(2,3)26-15-10-22(11-16-26)30-37-31(23-12-17-27(18-13-23)34(4,5)6)39-32(38-30)25-14-19-29(36-21-25)24-8-7-9-28(35)20-24;1-33(2,3)27-17-12-24(13-18-27)30-36-31(25-14-19-28(20-15-25)34(4,5)6)38-32(37-30)26-16-21-29(35-22-26)23-10-8-7-9-11-23;1-11-13-15-17-19-23-21-26(32-35-29(7,8)30(9,10)36-32)24(20-18-16-14-12-2)22-25(23)31-33-27(3,4)28(5,6)34-31;/h26-37,39-47H,10-25,38H2,1-9H3;19-22,27-30H,9-18,23-26H2,1-8H3;7,9-21H,1-6H3;7-10,12-22H,1-6H3;11-12,21-22H,1-2,13-20H2,3-10H3;/q;;2*-1;;
InChIKeyOBTOXSXPJJEEFI-UHFFFAOYSA-N
XLogP54.21
TPSA183.44 Ų
H-Bond Donors
H-Bond Acceptors18
Rotatable Bonds58
Heavy Atoms237
Complexity

Lipinski Rule of Five

3 violations

RuleValue
MW ≤ 5003534.60
LogP ≤ 554.21
H-Bond Donors ≤ 50
H-Bond Acceptors ≤ 1018

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'Aliphatic_long_chain', 'substructure': 'N/A'}, {'alert_name': 'Carbo_cation/anion', 'substructure': 'N/A'}, {'alert_name': 'heavy_metal', 'substructure': 'N/A'}, {'alert_name': 'isolated_alkene', 'substructure': 'N/A'}

Analyze 2-[2,5-bis[5-(3-bicyclo[4.2.0]octa-1(6),2,4-trienyl)pentyl]-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl]-4,4,5,5-tetramethyl-1,3,2-dioxaborolane;2-N,7-N-bis(4-bromophenyl)-9-(3,5-dihexylphenyl)-9-octyl-2-N,7-N-bis(2,4,6-trimethylphenyl)fluorene-2,7-diamine;2,4-bis(4-tert-butylphenyl)-6-(6-phenyl-3-pyridinyl)-1,3,5-triazine;2-[2,5-bis(hex-5-enyl)-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl]-4,4,5,5-tetramethyl-1,3,2-dioxaborolane;2-[6-(3-bromobenzene-6-id-1-yl)-3-pyridinyl]-4,6-bis(4-tert-butylphenyl)-1,3,5-triazine;iridium with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of 2-[2,5-bis[5-(3-bicyclo[4.2.0]octa-1(6),2,4-trienyl)pentyl]-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl]-4,4,5,5-tetramethyl-1,3,2-dioxaborolane;2-N,7-N-bis(4-bromophenyl)-9-(3,5-dihexylphenyl)-9-octyl-2-N,7-N-bis(2,4,6-trimethylphenyl)fluorene-2,7-diamine;2,4-bis(4-tert-butylphenyl)-6-(6-phenyl-3-pyridinyl)-1,3,5-triazine;2-[2,5-bis(hex-5-enyl)-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl]-4,4,5,5-tetramethyl-1,3,2-dioxaborolane;2-[6-(3-bromobenzene-6-id-1-yl)-3-pyridinyl]-4,6-bis(4-tert-butylphenyl)-1,3,5-triazine;iridium?
The IUPAC name of 2-[2,5-bis[5-(3-bicyclo[4.2.0]octa-1(6),2,4-trienyl)pentyl]-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl]-4,4,5,5-tetramethyl-1,3,2-dioxaborolane;2-N,7-N-bis(4-bromophenyl)-9-(3,5-dihexylphenyl)-9-octyl-2-N,7-N-bis(2,4,6-trimethylphenyl)fluorene-2,7-diamine;2,4-bis(4-tert-butylphenyl)-6-(6-phenyl-3-pyridinyl)-1,3,5-triazine;2-[2,5-bis(hex-5-enyl)-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl]-4,4,5,5-tetramethyl-1,3,2-dioxaborolane;2-[6-(3-bromobenzene-6-id-1-yl)-3-pyridinyl]-4,6-bis(4-tert-butylphenyl)-1,3,5-triazine;iridium (CID 159314253) is 2-[2,5-bis[5-(3-bicyclo[4.2.0]octa-1(6),2,4-trienyl)pentyl]-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl]-4,4,5,5-tetramethyl-1,3,2-dioxaborolane;2-N,7-N-bis(4-bromophenyl)-9-(3,5-dihexylphenyl)-9-octyl-2-N,7-N-bis(2,4,6-trimethylphenyl)fluorene-2,7-diamine;2,4-bis(4-tert-butylphenyl)-6-(6-phenyl-3-pyridinyl)-1,3,5-triazine;2-[2,5-bis(hex-5-enyl)-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl]-4,4,5,5-tetramethyl-1,3,2-dioxaborolane;2-[6-(3-bromobenzene-6-id-1-yl)-3-pyridinyl]-4,6-bis(4-tert-butylphenyl)-1,3,5-triazine;iridium.
What is the SMILES notation for 2-[2,5-bis[5-(3-bicyclo[4.2.0]octa-1(6),2,4-trienyl)pentyl]-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl]-4,4,5,5-tetramethyl-1,3,2-dioxaborolane;2-N,7-N-bis(4-bromophenyl)-9-(3,5-dihexylphenyl)-9-octyl-2-N,7-N-bis(2,4,6-trimethylphenyl)fluorene-2,7-diamine;2,4-bis(4-tert-butylphenyl)-6-(6-phenyl-3-pyridinyl)-1,3,5-triazine;2-[2,5-bis(hex-5-enyl)-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl]-4,4,5,5-tetramethyl-1,3,2-dioxaborolane;2-[6-(3-bromobenzene-6-id-1-yl)-3-pyridinyl]-4,6-bis(4-tert-butylphenyl)-1,3,5-triazine;iridium?
The canonical SMILES for 2-[2,5-bis[5-(3-bicyclo[4.2.0]octa-1(6),2,4-trienyl)pentyl]-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl]-4,4,5,5-tetramethyl-1,3,2-dioxaborolane;2-N,7-N-bis(4-bromophenyl)-9-(3,5-dihexylphenyl)-9-octyl-2-N,7-N-bis(2,4,6-trimethylphenyl)fluorene-2,7-diamine;2,4-bis(4-tert-butylphenyl)-6-(6-phenyl-3-pyridinyl)-1,3,5-triazine;2-[2,5-bis(hex-5-enyl)-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl]-4,4,5,5-tetramethyl-1,3,2-dioxaborolane;2-[6-(3-bromobenzene-6-id-1-yl)-3-pyridinyl]-4,6-bis(4-tert-butylphenyl)-1,3,5-triazine;iridium is C=CCCCCc1cc(B2OC(C)(C)C(C)(C)O2)c(CCCCC=C)cc1B1OC(C)(C)C(C)(C)O1.CC(C)(C)c1ccc(-c2nc(-c3ccc(C(C)(C)C)cc3)nc(-c3ccc(-c4[c-]ccc(Br)c4)nc3)n2)cc1.CC(C)(C)c1ccc(-c2nc(-c3ccc(C(C)(C)C)cc3)nc(-c3ccc(-c4[c-]cccc4)nc3)n2)cc1.CC1(C)OB(c2cc(CCCCCc3ccc4c(c3)CC4)c(B3OC(C)(C)C(C)(C)O3)cc2CCCCCc2ccc3c(c2)CC3)OC1(C)C.CCCCCCCCC1(c2cc(CCCCCC)cc(CCCCCC)c2)c2cc(N(c3ccc(Br)cc3)c3c(C)cc(C)cc3C)ccc2-c2ccc(N(c3ccc(Br)cc3)c3c(C)cc(C)cc3C)cc21.[Ir].
What is the InChIKey of 2-[2,5-bis[5-(3-bicyclo[4.2.0]octa-1(6),2,4-trienyl)pentyl]-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl]-4,4,5,5-tetramethyl-1,3,2-dioxaborolane;2-N,7-N-bis(4-bromophenyl)-9-(3,5-dihexylphenyl)-9-octyl-2-N,7-N-bis(2,4,6-trimethylphenyl)fluorene-2,7-diamine;2,4-bis(4-tert-butylphenyl)-6-(6-phenyl-3-pyridinyl)-1,3,5-triazine;2-[2,5-bis(hex-5-enyl)-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl]-4,4,5,5-tetramethyl-1,3,2-dioxaborolane;2-[6-(3-bromobenzene-6-id-1-yl)-3-pyridinyl]-4,6-bis(4-tert-butylphenyl)-1,3,5-triazine;iridium?
The InChIKey is OBTOXSXPJJEEFI-UHFFFAOYSA-N. The full InChI is InChI=1S/C69H82Br2N2.C44H60B2O4.C34H32BrN4.C34H33N4.C30H48B2O4.Ir/c1-10-13-16-19-20-23-38-69(56-44-54(24-21-17-14-11-2)43-55(45-56)25-22-18-15-12-3)65-46-61(72(59-30-26-57(70)27-31-59)67-50(6)39-48(4)40-51(67)7)34-36-63(65)64-37-35-62(47-66(64)69)73(60-32-28-58(71)29-33-60)68-52(8)41-49(5)42-53(68)9;1-41(2)42(3,4)48-45(47-41)39-29-38(18-14-10-12-16-32-20-22-34-24-26-36(34)28-32)40(46-49-43(5,6)44(7,8)50-46)30-37(39)17-13-9-11-15-31-19-21-33-23-25-35(33)27-31;1-33(2,3)26-15-10-22(11-16-26)30-37-31(23-12-17-27(18-13-23)34(4,5)6)39-32(38-30)25-14-19-29(36-21-25)24-8-7-9-28(35)20-24;1-33(2,3)27-17-12-24(13-18-27)30-36-31(25-14-19-28(20-15-25)34(4,5)6)38-32(37-30)26-16-21-29(35-22-26)23-10-8-7-9-11-23;1-11-13-15-17-19-23-21-26(32-35-29(7,8)30(9,10)36-32)24(20-18-16-14-12-2)22-25(23)31-33-27(3,4)28(5,6)34-31;/h26-37,39-47H,10-25,38H2,1-9H3;19-22,27-30H,9-18,23-26H2,1-8H3;7,9-21H,1-6H3;7-10,12-22H,1-6H3;11-12,21-22H,1-2,13-20H2,3-10H3;/q;;2*-1;;.
What are the key properties of 2-[2,5-bis[5-(3-bicyclo[4.2.0]octa-1(6),2,4-trienyl)pentyl]-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl]-4,4,5,5-tetramethyl-1,3,2-dioxaborolane;2-N,7-N-bis(4-bromophenyl)-9-(3,5-dihexylphenyl)-9-octyl-2-N,7-N-bis(2,4,6-trimethylphenyl)fluorene-2,7-diamine;2,4-bis(4-tert-butylphenyl)-6-(6-phenyl-3-pyridinyl)-1,3,5-triazine;2-[2,5-bis(hex-5-enyl)-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl]-4,4,5,5-tetramethyl-1,3,2-dioxaborolane;2-[6-(3-bromobenzene-6-id-1-yl)-3-pyridinyl]-4,6-bis(4-tert-butylphenyl)-1,3,5-triazine;iridium?
2-[2,5-bis[5-(3-bicyclo[4.2.0]octa-1(6),2,4-trienyl)pentyl]-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl]-4,4,5,5-tetramethyl-1,3,2-dioxaborolane;2-N,7-N-bis(4-bromophenyl)-9-(3,5-dihexylphenyl)-9-octyl-2-N,7-N-bis(2,4,6-trimethylphenyl)fluorene-2,7-diamine;2,4-bis(4-tert-butylphenyl)-6-(6-phenyl-3-pyridinyl)-1,3,5-triazine;2-[2,5-bis(hex-5-enyl)-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl]-4,4,5,5-tetramethyl-1,3,2-dioxaborolane;2-[6-(3-bromobenzene-6-id-1-yl)-3-pyridinyl]-4,6-bis(4-tert-butylphenyl)-1,3,5-triazine;iridium has a molecular weight of 3534.60 g/mol, XLogP of 54.21, 58 rotatable bonds, 0 hydrogen bond donors, and 18 hydrogen bond acceptors.
Where does this data come from?
All data for 2-[2,5-bis[5-(3-bicyclo[4.2.0]octa-1(6),2,4-trienyl)pentyl]-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl]-4,4,5,5-tetramethyl-1,3,2-dioxaborolane;2-N,7-N-bis(4-bromophenyl)-9-(3,5-dihexylphenyl)-9-octyl-2-N,7-N-bis(2,4,6-trimethylphenyl)fluorene-2,7-diamine;2,4-bis(4-tert-butylphenyl)-6-(6-phenyl-3-pyridinyl)-1,3,5-triazine;2-[2,5-bis(hex-5-enyl)-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl]-4,4,5,5-tetramethyl-1,3,2-dioxaborolane;2-[6-(3-bromobenzene-6-id-1-yl)-3-pyridinyl]-4,6-bis(4-tert-butylphenyl)-1,3,5-triazine;iridium is sourced from PubChem (CID 159314253), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).